chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Feeling abnormal, Hyperhidrosis, Myalgia
Clinical narrative: Chills; Heaviness with breathing; Extreme sweating; body aches and pain; felt like organs was being shifted and squeezed.; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), DYSPNOEA (Heaviness with breathing), HYPERHIDROSIS (Extreme sweating), MYALGIA (body aches and pain) and FEELING ABNORMAL (felt like organs was being shifted and squeezed.) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced CHILLS (Chills), DYSPNOEA (Heaviness with breathing), HYPERHIDROSIS (Extreme sweating), MYALGIA (body aches and pain) and FEELING ABNORMAL (felt like organs was being shifted and squeezed.). At the time of the report, CHILLS (Chills), DYSPNOEA (Heaviness with breathing), HYPERHIDROSIS (Extreme sweating), MYALGIA (body aches and pain) and FEELING ABNORMAL (felt like organs was being shifted and squeezed.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pruritus
Clinical narrative: Itchy all over his body; Shivering; Itchy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy), PRURITUS (Itchy all over his body) and CHILLS (Shivering) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PRURITUS (Itchy) and CHILLS (Shivering). On an unknown date, the patient experienced PRURITUS (Itchy all over his body). On 16-Feb-2021, PRURITUS (Itchy) and CHILLS (Shivering) had resolved. At the time of the report, PRURITUS (Itchy all over his body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site anaesthesia, Vaccination site lymphadenopathy
Clinical narrative: arm went numb immediately; extreme swelling in her lymph nodes (clavicle) its getting bigger and bigger; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ANAESTHESIA (arm went numb immediately) and VACCINATION SITE LYMPHADENOPATHY (extreme swelling in her lymph nodes (clavicle) its getting bigger and bigger) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ANAESTHESIA (arm went numb immediately) and VACCINATION SITE LYMPHADENOPATHY (extreme swelling in her lymph nodes (clavicle) its getting bigger and bigger). At the time of the report, VACCINATION SITE ANAESTHESIA (arm went numb immediately) and VACCINATION SITE LYMPHADENOPATHY (extreme swelling in her lymph nodes (clavicle) its getting bigger and bigger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment information was not provided  concomitant drugs were  not reported    Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: fallow up received on 27-APR-2021 patient refused for fallow up
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Discomfort, Illness, Nausea, Pain
Clinical narrative: On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (General discomfort), PAIN (pain in the site), NAUSEA (not sick, don't feel nauseated), ILLNESS (just don't feel well.) and ARTHRALGIA (sore shoulder). At the time of the report, DISCOMFORT (General discomfort), PAIN (pain in the site), NAUSEA (not sick, don't feel nauseated), ILLNESS (just don't feel well.) and ARTHRALGIA (sore shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pain
Clinical narrative: Body aches; Headache; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (Body aches), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea). On 22-Feb-2021, PAIN (Body aches), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea) had resolved.            No relevant concomitant medications were reported. No treatment information was reported. Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Outcome of the events updated. Duration of the event added as 5 days.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Abscess, Pain
Clinical narrative: Abscess on bottom; Sore spot on bottom; This spontaneous case was reported by a consumer and describes the occurrence of ABSCESS (Abscess on bottom) and PAIN (Sore spot on bottom) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20a) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced ABSCESS (Abscess on bottom) and PAIN (Sore spot on bottom). At the time of the report, ABSCESS (Abscess on bottom) and PAIN (Sore spot on bottom) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoglycaemia
Clinical narrative: drop in blood sugar level; This spontaneous case was reported by a consumer and describes the occurrence of HYPOGLYCAEMIA (drop in blood sugar level) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes mellitus.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced HYPOGLYCAEMIA (drop in blood sugar level). At the time of the report, HYPOGLYCAEMIA (drop in blood sugar level) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medication information was provided. No treatment medication were provided.  The patient did not report any adverse reactions after the second dose.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jul-2021: Added dose 2 details.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Neck pain
Clinical narrative: Diarrhea; cracking neck/pain in neck; Pain in right shoulder; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), NECK PAIN (cracking neck/pain in neck) and ARTHRALGIA (Pain in right shoulder) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced DIARRHOEA (Diarrhea), NECK PAIN (cracking neck/pain in neck) and ARTHRALGIA (Pain in right shoulder). At the time of the report, DIARRHOEA (Diarrhea), NECK PAIN (cracking neck/pain in neck) and ARTHRALGIA (Pain in right shoulder) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant drugs were reported. No treatment medications were reported.   This case was linked to MOD-2021-024627 (Dose 2 case) (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Telephone Contact Report received and event onset dates and outcomes were updated.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: Arm tightness; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Arm tightness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine. Concomitant products included AMLODIPINE, LOSARTAN POTASSIUM (COZARIL), ROSUVASTATIN CALCIUM (CRESTOR), OMEPRAZOLE (OPRIL [OMEPRAZOLE]), TAMSULOSIN, TOPIRAMATE (TOPAMAX), TRAZODONE and EZETIMIBE (ZETIA) for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Arm tightness). At the time of the report, LIMB DISCOMFORT (Arm tightness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Hyperhidrosis, Loss of consciousness, Nausea
Clinical narrative: Passed out for about one minute; Vomiting; Chills; Sweat; Decreased appetite; Mild fever/Higher fever; Sore arm; Nauseated; A spontaneous report, was received from a health care professional (patient's husband), concerning a 33-year-old female patient, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine, and experienced passed out for about one minute (loss of consciousness), sore arm (pain in extremity), sweat (hyperhidrosis), decreased appetite, mild fever/higher fever (pyrexia), chills, vomiting, and nauseated (nausea).   The patient's medical history was not provided. No relevant concomitant medications were reported. No information on allergies were provided. The reported stated that the patient was physically and mentally healthy before vaccination.   On 10 Feb 2021, prior to the onset of events, the patient received their second planned dose of mRNA-1273 (lot number: 038K20), intramuscularly into left upper arm for the prophylaxis of COVID-19 infection.  On 10 Feb 2021, after the second dose of vaccine, the patient experienced sore arm, and mild fever/higher fever. On 11 Feb 2021, the patient developed chills, sweat, and decreased appetite. The patient has passed out for about a minute and started vomiting on 12 Feb 2021. The patient did not seek any medical emergency. The patient was nauseated on an unknown date in Feb 2021. The patient received treatment medication with ibuprofen twice within 12 hours of adverse events apart. The patient was currently not taking any other medications.  The outcome for the events, passed out for about one-minute, sore arm, sweat, decreased appetite, mild fever/higher fever, chills, vomiting, and nauseate, were reported as unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Vomiting
Clinical narrative: Passed out for about one minute; Vomiting; Chills; Sweat; Decreased appetite; Mild fever/Higher fever; Sore arm; Nauseated; A spontaneous report, was received from a health care professional (patient's husband), concerning a 33-year-old female patient, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine, and experienced passed out for about one minute (loss of consciousness), sore arm (pain in extremity), sweat (hyperhidrosis), decreased appetite, mild fever/higher fever (pyrexia), chills, vomiting, and nauseated (nausea).   The patient's medical history was not provided. No relevant concomitant medications were reported. No information on allergies were provided. The reported stated that the patient was physically and mentally healthy before vaccination.   On 10 Feb 2021, prior to the onset of events, the patient received their second planned dose of mRNA-1273 (lot number: 038K20), intramuscularly into left upper arm for the prophylaxis of COVID-19 infection.  On 10 Feb 2021, after the second dose of vaccine, the patient experienced sore arm, and mild fever/higher fever. On 11 Feb 2021, the patient developed chills, sweat, and decreased appetite. The patient has passed out for about a minute and started vomiting on 12 Feb 2021. The patient did not seek any medical emergency. The patient was nauseated on an unknown date in Feb 2021. The patient received treatment medication with ibuprofen twice within 12 hours of adverse events apart. The patient was currently not taking any other medications.  The outcome for the events, passed out for about one-minute, sore arm, sweat, decreased appetite, mild fever/higher fever, chills, vomiting, and nauseate, were reported as unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Body aches; Fever; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), PYREXIA (Fever), HEADACHE (Headache) and CHILLS (Chills) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (Body aches), PYREXIA (Fever), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, PAIN (Body aches), PYREXIA (Fever), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Rash, Vaccination site pruritus
Clinical narrative: Rash 3-4 times larger than the injection site, lumpy rash; Itchy near injection site; Discomfort; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Discomfort), VACCINATION SITE PRURITUS (Itchy near injection site) and RASH (Rash 3-4 times larger than the injection site, lumpy rash) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced DISCOMFORT (Discomfort). On 17-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy near injection site). On 18-Feb-2021, the patient experienced RASH (Rash 3-4 times larger than the injection site, lumpy rash). On 12-Feb-2021, DISCOMFORT (Discomfort) had resolved. On 18-Feb-2021, VACCINATION SITE PRURITUS (Itchy near injection site) had resolved. At the time of the report, RASH (Rash 3-4 times larger than the injection site, lumpy rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Pain in extremity, SARS-CoV-2 test
Clinical narrative: I got tested positive for covid; Pain in arm; Fatigue, super tired; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I got tested positive for covid), PAIN IN EXTREMITY (Pain in arm) and FATIGUE (Fatigue, super tired) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concomitant products included INSULIN ASPART (NOVOLOG), INSULIN DEGLUDEC (TRESIBA), BUSPIRONE, PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), METOPROLOL and FLUDROCORTISONE for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm) and FATIGUE (Fatigue, super tired). On 06-Feb-2021, the patient experienced COVID-19 (I got tested positive for covid). At the time of the report, COVID-19 (I got tested positive for covid), PAIN IN EXTREMITY (Pain in arm) and FATIGUE (Fatigue, super tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Feb-2021, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling, Malaise
Clinical narrative: Swelling in the joints of both her thumbs; Was very very ill; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Was very very ill) and JOINT SWELLING (Swelling in the joints of both her thumbs) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol. Concomitant products included EZETIMIBE and SIMVASTATIN for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced MALAISE (Was very very ill). On 21-Feb-2021, the patient experienced JOINT SWELLING (Swelling in the joints of both her thumbs). At the time of the report, MALAISE (Was very very ill) outcome was unknown and JOINT SWELLING (Swelling in the joints of both her thumbs) had resolved. Not Provided
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pain
Clinical narrative: every inch of her body was hurting; Nauseous; Chilled but not sweat; Terrible headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (every inch of her body was hurting), NAUSEA (Nauseous), CHILLS (Chilled but not sweat) and HEADACHE (Terrible headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (every inch of her body was hurting), NAUSEA (Nauseous), CHILLS (Chilled but not sweat) and HEADACHE (Terrible headache). On 19-Feb-2021, PAIN (every inch of her body was hurting), NAUSEA (Nauseous), CHILLS (Chilled but not sweat) and HEADACHE (Terrible headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-017482 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-017482:same reporter , different patient.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Rash on arm; red; bumpy; itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on arm), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE MASS (bumpy) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2020, the patient experienced VACCINATION SITE PRURITUS (itchy). On 19-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash on arm), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE MASS (bumpy). At the time of the report, VACCINATION SITE RASH (Rash on arm), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE MASS (bumpy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Groin pain, Intentional product use issue
Clinical narrative: Cancelled second covid shot scheduled for 23feb2021; pain progressed to mid back; pain progressed to low back; Pain in her groin area; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of GROIN PAIN (Pain in her groin area), BACK PAIN (pain progressed to low back), BACK PAIN (pain progressed to mid back) and INTENTIONAL PRODUCT USE ISSUE (Cancelled second covid shot scheduled for 23feb2021) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042320A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 27-Nov-2020 and Arrhythmia (NOS) (arrhythmias after having covid) from 15-Dec-2020 to 19-Feb-2021. Concurrent medical conditions included Drug allergy (blood pressure medications) and Drug allergy (aspirin). Concomitant products included CALCIUM CARBONATE, VITAMIN D NOS (CALCIUM + VIT D) and BIOTIN for Routine health maintenance.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced GROIN PAIN (Pain in her groin area). On 08-Feb-2021, the patient experienced BACK PAIN (pain progressed to low back). On 15-Feb-2021, the patient experienced BACK PAIN (pain progressed to mid back). On 19-Feb-2021, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Cancelled second covid shot scheduled for 23feb2021). The patient was treated with METHYLPREDNISOLONE (METHYLPREDNISOLON [METHYLPREDNISOLONE]) at a dose of 1 dosage form and KETOROLAC TROMETHAMINE (TORADOL) at a dose of 1 dosage form. On 19-Feb-2021, INTENTIONAL PRODUCT USE ISSUE (Cancelled second covid shot scheduled for 23feb2021) had resolved. At the time of the report, GROIN PAIN (Pain in her groin area), BACK PAIN (pain progressed to low back) and BACK PAIN (pain progressed to mid back) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       Other concomitant product included Mukta Vati for blood pressure.   On unknow date, Magnetic resonance imaging was performed and result was unknown.     Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: updated allergy, historical condition, concomitant medicationsadded one additional eventupdated events outcome from not recovered/resolved  to recovered/resolved,
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Behavioural therapy, Neuropsychiatric symptoms
Clinical narrative: vaccine has something that improved her condition; Feels more aware overall; Significant cognitive improvement; This spontaneous case was reported by a consumer and describes the occurrence of NEUROPSYCHIATRIC SYMPTOMS (vaccine has something that improved her condition), ANXIETY (Feels more aware overall) and BEHAVIOURAL THERAPY (Significant cognitive improvement) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Dementia.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NEUROPSYCHIATRIC SYMPTOMS (vaccine has something that improved her condition), ANXIETY (Feels more aware overall) and BEHAVIOURAL THERAPY (Significant cognitive improvement). At the time of the report, NEUROPSYCHIATRIC SYMPTOMS (vaccine has something that improved her condition), ANXIETY (Feels more aware overall) and BEHAVIOURAL THERAPY (Significant cognitive improvement) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Temperature; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Temperature) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced PYREXIA (Temperature). At the time of the report, PYREXIA (Temperature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced RASH (rash). At the time of the report, RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Sore shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Sore shoulder) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concomitant products included RABEPRAZOLE SODIUM (ACIPHEX), METOPROLOL SUCCINATE (TOPROL), GABAPENTIN and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ARTHRALGIA (Sore shoulder). On 11-Feb-2021, ARTHRALGIA (Sore shoulder) had resolved. Not Provided          This case was linked to MOD-2021-017442 (Linked Report).; Sender's Comments:  MOD-2021-017442:same reorter, different patient
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Rash
Clinical narrative: Rashes on her back; Rash on neck and little on arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rashes on her back) and INJECTION SITE RASH (Rash on neck and little on arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced RASH (Rashes on her back) and INJECTION SITE RASH (Rash on neck and little on arm). The patient was treated with XIPAMIDE (AQUAPHOR [XIPAMIDE]) for Rash, at an unspecified dose and frequency. At the time of the report, RASH (Rashes on her back) and INJECTION SITE RASH (Rash on neck and little on arm) had resolved.            No relevant concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow-up information received on 14-JUL-2021 and the outcome of the events has been updated from unknown to resolved.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness of arm; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021. The most recent information was received on 14-Jul-2021 and was forwarded to Moderna on 14-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included Pain in arm (Patient stated she had the typical symptoms of a sore arm with any vaccine.).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness of arm). At the time of the report, PAIN IN EXTREMITY (Soreness of arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow-up information received on 14-Jul-2021 and included Newmedical history (typical symptoms of a sore arm with any vaccine) was added in patient medical history.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Flatulence, Gastrooesophageal reflux disease, Rash, Vaccination site rash
Clinical narrative: rash came on the inside of her elbow on the other arm; rash on the arm of the shot, near the elbow on the underside of her arm; dizzy; trouble with acid reflux; lost of gas; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (trouble with acid reflux), FLATULENCE (lost of gas), VACCINATION SITE RASH (rash on the arm of the shot, near the elbow on the underside of her arm) and RASH (rash came on the inside of her elbow on the other arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     Concomitant products included PROGESTERONE and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (trouble with acid reflux) and FLATULENCE (lost of gas). On 14-Feb-2021, the patient experienced VACCINATION SITE RASH (rash on the arm of the shot, near the elbow on the underside of her arm). On 15-Feb-2021, the patient experienced RASH (rash came on the inside of her elbow on the other arm). At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (trouble with acid reflux), FLATULENCE (lost of gas) and VACCINATION SITE RASH (rash on the arm of the shot, near the elbow on the underside of her arm) outcome was unknown and RASH (rash came on the inside of her elbow on the other arm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication include thyroid medication, implant with hormones. Treatment medication included diet.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Heart rate, Heart rate increased
Clinical narrative: rapid heart rate; rash on entire torso; Felt tired; Low grade temperature; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid heart rate), RASH (rash on entire torso), PYREXIA (Low grade temperature), CHILLS (Chills) and FATIGUE (Felt tired) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for Heart beat abnormal neonatal.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced PYREXIA (Low grade temperature) and CHILLS (Chills). On an unknown date, the patient experienced HEART RATE INCREASED (rapid heart rate) and FATIGUE (Felt tired). an unknown date, the patient experienced RASH (rash on entire torso). On 18-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, HEART RATE INCREASED (rapid heart rate), RASH (rash on entire torso) and FATIGUE (Felt tired) outcome was unknown and PYREXIA (Low grade temperature) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 38 (High) low grade temperature 100.4 F. On an unknown date, Heart rate: 112 (Inconclusive) 112.         No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: additional event reported (rash on entire torso).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash
Clinical narrative: rapid heart rate; rash on entire torso; Felt tired; Low grade temperature; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid heart rate), RASH (rash on entire torso), PYREXIA (Low grade temperature), CHILLS (Chills) and FATIGUE (Felt tired) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for Heart beat abnormal neonatal.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced PYREXIA (Low grade temperature) and CHILLS (Chills). On an unknown date, the patient experienced HEART RATE INCREASED (rapid heart rate) and FATIGUE (Felt tired). an unknown date, the patient experienced RASH (rash on entire torso). On 18-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, HEART RATE INCREASED (rapid heart rate), RASH (rash on entire torso) and FATIGUE (Felt tired) outcome was unknown and PYREXIA (Low grade temperature) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 38 (High) low grade temperature 100.4 F. On an unknown date, Heart rate: 112 (Inconclusive) 112.         No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: additional event reported (rash on entire torso).
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: woke up and she had extremely sore arm at the injection site; Warm to touch; Little itchy; and red at the injection site; Sore around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (woke up and she had extremely sore arm at the injection site), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Little itchy), VACCINATION SITE ERYTHEMA (and red at the injection site) and VACCINATION SITE PAIN (Sore around the injection site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 048A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hyperlipidemia. Concomitant products included RALOXIFENE and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore around the injection site). On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (woke up and she had extremely sore arm at the injection site), VACCINATION SITE WARMTH (Warm to touch) and VACCINATION SITE ERYTHEMA (and red at the injection site). 19-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Little itchy). At the time of the report, PAIN IN EXTREMITY (woke up and she had extremely sore arm at the injection site) was resolving and VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Little itchy), VACCINATION SITE ERYTHEMA (and red at the injection site) and VACCINATION SITE PAIN (Sore around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included Cholesterol medication  Treatment medication were not provided.   On 19-Feb-2021, the patient's arm was not as sore when she woke up,but it was still red, warm and little itchy  The patient had no side effects after the second dose.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Follow up received on 28-APR-2021 contains non significant information:Address was updated. On 14-Jul-2021: Follow-up received on 14-JUL-2021 contains significant information: Batch number  and route of administration for first dose updated.Second dose information updated.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue
Clinical narrative: Has very low appetite; Extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Has very low appetite) and FATIGUE (Extremely tired) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced DECREASED APPETITE (Has very low appetite) and FATIGUE (Extremely tired). On 20-Feb-2021, DECREASED APPETITE (Has very low appetite) and FATIGUE (Extremely tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Additional info: TCR : updated events outcome from unknown to recovered.
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Pain
Clinical narrative: Lightheaded/ Dizziness; Chills; Slight soreness; A spontaneous report was received from a consumer concerning her mother, a  95-year-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the events; slight soreness/pain, lightheadness/dizziness and chills.  The patient's medical history was not provided. Concomitant medication list was not provided by the reporter.  The patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) on 20 Jan 2021 .  On 17 Feb 2021 the patient received their second of two planned doses of mRNA-1273 (Batch number: unknown) intramuscularly in an unspecified arm for the prophylaxis of COVID-19 infection.  On 17 Feb 2021, after receiving mRNA-1273 the patient experienced slight soreness and chills. 48 hours later that is on 19 Feb 2021, the patient started feeling lightheaded and dizziness. It comes and goes but still happens everyday. Treatment provided for the events were not provided.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.  The outcome of the events; slight soreness, lightheadnes/dizziness and chills was considered to be unknown.  Follow up received on 26 Feb 2021include the event that occurred two days after second dose of mRNA-1273; dizziness/lightheadness.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Infection, Insomnia, Pain in extremity, Peripheral swelling
Clinical narrative: infection; left leg was swollen; left leg was sore; (sore leg) it woke her up a couple of times throughout the night; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (left leg was sore), PERIPHERAL SWELLING (left leg was swollen), INFECTION (infection) and INSOMNIA ((sore leg) it woke her up a couple of times throughout the night) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No medication history information was reported .  Concomitant products included HYDROXYCARBAMIDE (HYDREA) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (left leg was sore) and INSOMNIA ((sore leg) it woke her up a couple of times throughout the night). On 13-Feb-2021, the patient experienced PERIPHERAL SWELLING (left leg was swollen). On 15-Feb-2021, the patient experienced INFECTION (infection). At the time of the report, PAIN IN EXTREMITY (left leg was sore), PERIPHERAL SWELLING (left leg was swollen), INFECTION (infection) and INSOMNIA ((sore leg) it woke her up a couple of times throughout the night) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include supplements. Treatment medication include antibiotics.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received on 23-Jul-2021 and contains no new information.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Site of injection feels worm; Site of injection has red mark; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Site of injection feels worm) and VACCINATION SITE ERYTHEMA (Site of injection has red mark) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Site of injection feels worm) and VACCINATION SITE ERYTHEMA (Site of injection has red mark). At the time of the report, VACCINATION SITE WARMTH (Site of injection feels worm) and VACCINATION SITE ERYTHEMA (Site of injection has red mark) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was provided   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: NNI
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Blood pressure measurement, Dizziness, Eye swelling
Clinical narrative: Loss of taste; Loss of smell; Sore arm; Light headed; Blurred vision; Weak knees; High BP (145); Swollen eyes; This spontaneous case was reported by an other health care professional and describes the occurrence of DIZZINESS (Light headed), VISION BLURRED (Blurred vision), MUSCULAR WEAKNESS (Weak knees), HYPERTENSION (High BP (145)) and EYE SWELLING (Swollen eyes) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included FENOFIBRATE, SERTRALINE, LOSARTAN and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced DIZZINESS (Light headed), VISION BLURRED (Blurred vision), MUSCULAR WEAKNESS (Weak knees), HYPERTENSION (High BP (145)), EYE SWELLING (Swollen eyes) and PAIN IN EXTREMITY (Sore arm). On 11-Feb-2021, the patient experienced AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell). On 08-Feb-2021, DIZZINESS (Light headed), VISION BLURRED (Blurred vision), MUSCULAR WEAKNESS (Weak knees), HYPERTENSION (High BP (145)) and EYE SWELLING (Swollen eyes) had resolved. At the time of the report, AGEUSIA (Loss of taste), ANOSMIA (Loss of smell) and PAIN IN EXTREMITY (Sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, Blood pressure measurement: 145 High. On 16-Feb-2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.